CNS Involvement in Hereditary Transthyretin Amyloidosis
Authors:
- 14 December 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology
- Vol. 97 (24) , 1111-1119
Abstract
Hereditary transthyretin amyloidosis (ATTRv amyloidosis) is predominantly a disease of the peripheral nerves, heart, kidney, and eye. CNS involvement has been a marginal issue in research and the clinical setting until recently. Growing evidence shows that leptomeningeal amyloid accumulation is frequent and present from early stages of ATTRv amyloidosis. Several recent studies show CNS symptoms arise as a common late complication in patients with the V30M mutation after at least 14 years of symptomatic peripheral nerve disease. Conversely, in non-V30M patients, there are several descriptions, mostly case reports, of patients presenting with severe phenotypes of ocular and CNS dysfunction (oculoleptomeningeal amyloidosis), with little systemic involvement. This phenotype is found in rare families worldwide, associated with at least 14 mutations. In both patients with late and early onset CNS dysfunction, symptoms include transient focal neurologic episodes, hemorrhagic and ischemic stroke, cognitive decline, and cranial nerve dysfunction. Pathologically, there is severe amyloid deposition in the leptomeninges and cerebral amyloid angiopathy of leptomeningeal and penetrating vessels. These amyloid aggregates are formed mostly by CSF-produced transthyretin (TTR) and seem resistant to the available ATTRv therapies that increase the stability or reduce the production of plasma TTR. This indicates that CNS involvement will become a meaningful issue in patient management in upcoming years.Keywords
This publication has 57 references indexed in Scilit:
- Bilateral optic neuropathy in a patient with familial amyloidotic polyneuropathyBMJ Case Reports, 2013
- THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosisCurrent Medical Research and Opinion, 2012
- Spectrum of Transient Focal Neurological Episodes in Cerebral Amyloid AngiopathyStroke, 2012
- Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areasJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Prevalence of superficial siderosis in patients with cerebral amyloid angiopathyNeurology, 2010
- Report of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in SwedenAmyloid, 2009
- EXTENSIVE INTRACRANIAL MICROBLEEDS IN TRANSTHYRETIN AMYLOIDOSISJournal of the American Geriatrics Society, 2008
- A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxiaJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Change in Variant Transthyretin Levels in Patients with Familial Amyloidotic Polyneuropathy Type I Following Liver TransplantationBiochemical and Biophysical Research Communications, 1995
- Portuguese Polyneuritic Familial Type of AmyloidosisPathobiology, 1964